☰ Navigation Tabs
New design for monovalent bispecific IgG through cysteine engineering of the CH1-CL interface External Resource: Annotation Chains Family Name Domain Identifier Architecture Possible Homology Homology Topology Family Provenance Source (Version) B [auth L] PTR2 e4ub0L1 A: alpha arrays X: cradle loop barrel H: RIFT-related T: acid protease F: PTR2 ECOD (v295.2) A [auth H] PTR2 e4ub0H2 A: alpha arrays X: cradle loop barrel H: RIFT-related T: acid protease F: PTR2 ECOD (v295.2) A [auth H] EF-hand_1, EF-hand_6, EF-hand_7 e4ub0H3 A: alpha arrays X: Lipocalins/Streptavidin H: SAM/DNA-glycosylase T: SAM domain-like F: EF-hand_1, EF-hand_6, EF-hand_7 ECOD (v295.2)
Chain Protein Name Description Organism Name Gene Allele Name(s) Domain Name(s) Receptor Type Receptor Description Provenance Source B [auth L] IgG1 Fab L-KAPPA Homo sapiens (human) IGKV1-39*01, IGKV1D-39*01, IGKJ1*01, IGKC*01 V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA IG FAB-GAMMA-1_KAPPA IMGT (202639-0) A [auth H] IgG1 Fab VH-CH1 Homo sapiens (human) IGHV3-66*01, IGHV3-66*02, IGHV3-66*04, IGHJ6*01, IGHJ6*02, IGHG1*01, IGHG1*02, IGHG1*04, IGHG1*05 V-DOMAIN VH, C-DOMAIN CH1 IG FAB-GAMMA-1_KAPPA IMGT (202639-0)
Chain Chain Class Chain Subclass Chain Type Antigen Name(s) Provenance Source B [auth L] Light Chain IGKV1 Kappa - SAbDab (2026-10-09) A [auth H] Heavy Chain IGHV3 - - SAbDab (2026-10-09)
Chain Name Target Provenance Source B [auth L] Timigutuzumab ERBB2/CD340/HER2, SIRPA, CD3E, TNFRSF9/CD137/4-1BB Therapeutic SAbDab (2026-10-09) A [auth H] Cinrebafusp ERBB2/CD340/HER2, SIRPA, CD3E, TNFRSF9/CD137/4-1BB Therapeutic SAbDab (2026-10-09)